• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型三血清磷脂谱可区分正常个体和前列腺癌患者。

A novel three serum phospholipid panel differentiates normal individuals from those with prostate cancer.

机构信息

Department of Laboratory Oncology Research, Memorial University Medical Center (MUMC) and Mercer University School of Medicine (MUSM), Anderson Cancer Institute, Savannah, Georgia, United States of America.

Georgia Southern University, Statesboro, Georgia, United States of America.

出版信息

PLoS One. 2014 Mar 6;9(3):e88841. doi: 10.1371/journal.pone.0088841. eCollection 2014.

DOI:10.1371/journal.pone.0088841
PMID:24603597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3945968/
Abstract

BACKGROUND

The results of prostate specific antigen (PSA) and digital rectal examination (DRE) screenings lead to both under and over treatment of prostate cancer (PCa). As such, there is an urgent need for the identification and evaluation of new markers for early diagnosis and disease prognosis. Studies have shown a link between PCa, lipids and lipid metabolism. Therefore, the aim of this study was to examine the concentrations and distribution of serum lipids in patients with PCa as compared with serum from controls.

METHOD

Using Electrospray ionization mass spectrometry (ESI-MS/MS) lipid profiling, we analyzed serum phospholipids from age-matched subjects who were either newly diagnosed with PCa or healthy (normal).

RESULTS

We found that cholester (CE), dihydrosphingomyelin (DSM), phosphatidylcholine (PC), egg phosphatidylcholine (ePC) and egg phosphatidylethanolamine (ePE) are the 5 major lipid groups that varied between normal and cancer serums. ePC 38:5, PC 40:3, and PC 42:4 represent the lipids species most prevalent in PCa as compared with normal serum. Further analysis revealed that serum ePC 38:5 ≥0.015 nmoles, PC 40.3 ≤0.001 nmoles and PC 42:4 ≤0.0001 nmoles correlated with the absence of PCa at 94% prediction. Conversely, serum ePC 38:5 ≤0.015 nmoles, PC 40:3 ≥0.001 nmoles, and PC 42:4 ≥0.0001 nmoles correlated with the presence of PCa.

CONCLUSION

In summary, we have demonstrated that ePC 38:5, PC 40:3, and PC 42:4 may serve as early predictive serum markers for the presence of PCa.

摘要

背景

前列腺特异性抗原(PSA)和直肠指检(DRE)筛查的结果导致前列腺癌(PCa)的过度治疗和治疗不足。因此,迫切需要识别和评估新的标志物用于早期诊断和疾病预后。研究表明,PCa 与脂质和脂质代谢之间存在关联。因此,本研究旨在检查 PCa 患者与对照血清相比,其血清脂质的浓度和分布。

方法

使用电喷雾电离质谱(ESI-MS/MS)脂质谱分析,我们分析了年龄匹配的新诊断为 PCa 或健康(正常)患者的血清磷脂。

结果

我们发现胆固醇(CE)、二氢神经酰胺(DSM)、磷脂酰胆碱(PC)、蛋黄磷脂酰胆碱(ePC)和蛋黄磷脂酰乙醇胺(ePE)是正常和癌症血清之间存在差异的 5 种主要脂质组。与正常血清相比,ePC 38:5、PC 40:3 和 PC 42:4 代表 PCa 中最常见的脂质种类。进一步分析表明,血清 ePC 38:5≥0.015nmoles、PC 40.3≤0.001nmoles 和 PC 42:4≤0.0001nmoles 与无 PCa 相关,预测准确率为 94%。相反,血清 ePC 38:5≤0.015nmoles、PC 40:3≥0.001nmoles 和 PC 42:4≥0.0001nmoles 与 PCa 存在相关。

结论

总之,我们已经证明,ePC 38:5、PC 40:3 和 PC 42:4 可能作为存在 PCa 的早期预测性血清标志物。

相似文献

1
A novel three serum phospholipid panel differentiates normal individuals from those with prostate cancer.一种新型三血清磷脂谱可区分正常个体和前列腺癌患者。
PLoS One. 2014 Mar 6;9(3):e88841. doi: 10.1371/journal.pone.0088841. eCollection 2014.
2
NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics.前列腺癌过滤血清的核磁共振波谱分析:代谢组学的一个新前沿。
Prostate. 2016 Sep;76(12):1106-19. doi: 10.1002/pros.23198. Epub 2016 May 16.
3
[The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].[直肠指检、前列腺特异性抗原及经直肠超声检查在前列腺癌诊断中的应用]
Arch Esp Urol. 1995 Apr;48(3):247-59.
4
Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume.前列腺特异性抗原密度与病理性显著前列腺癌的关系:前列腺体积的影响。
Prostate. 2020 Dec;80(16):1444-1449. doi: 10.1002/pros.24078. Epub 2020 Sep 24.
5
Alterations of serum phospholipids in patients with multiple sclerosis.多发性硬化症患者血清磷脂的变化。
Chin Med J (Engl). 1993 Sep;106(9):650-4.
6
Prostate Cancer Associated Lipid Signatures in Serum Studied by ESI-Tandem Mass Spectrometryas Potential New Biomarkers.通过电喷雾串联质谱法研究血清中前列腺癌相关脂质特征作为潜在的新型生物标志物
PLoS One. 2016 Mar 9;11(3):e0150253. doi: 10.1371/journal.pone.0150253. eCollection 2016.
7
Diagnosis of Prostate Cancer in Patients with Prostate-Specific Antigen (PSA) in the Gray Area: Construction of 2 Predictive Models.前列腺特异性抗原(PSA)灰区患者前列腺癌的诊断:2 种预测模型的构建。
Med Sci Monit. 2021 Feb 8;27:e929913. doi: 10.12659/MSM.929913.
8
Prostate Volume Index Is Able to Differentiate between Prostatic Chronic Inflammation and Prostate Cancer in Patients with Normal Digital Rectal Examination and Prostate-Specific Antigen Values <10 ng/mL: Results of 564 Biopsy Naïve Cases.前列腺体积指数能够在直肠指检正常且前列腺特异性抗原值<10 ng/mL的患者中区分前列腺慢性炎症和前列腺癌:564例未经活检病例的结果
Urol Int. 2019;103(4):415-422. doi: 10.1159/000502659. Epub 2019 Aug 29.
9
Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.在前列腺癌筛查中使用低游离 PSA 与总 PSA 比值:血清 PSA 水平<4.0ng/mL 的巴西男性中的检出率、临床和病理发现。
BJU Int. 2012 Dec;110(11 Pt B):E653-7. doi: 10.1111/j.1464-410X.2012.11398.x. Epub 2012 Aug 14.
10
Correlation of serum β2-microglobulin levels with prostate-specific antigen, Gleason score, clinical stage, tumor metastasis and therapy efficacy in prostate cancer.血清β2-微球蛋白水平与前列腺癌中前列腺特异性抗原、Gleason 评分、临床分期、肿瘤转移及治疗效果的相关性。
Arch Med Res. 2013 May;44(4):259-65. doi: 10.1016/j.arcmed.2013.03.008. Epub 2013 May 22.

引用本文的文献

1
Metabolomic profile and its association with the diagnosis of prostate cancer: a systematic review.代谢组学特征及其与前列腺癌诊断的关联:一项系统综述。
J Cancer Res Clin Oncol. 2024 Dec 31;151(1):29. doi: 10.1007/s00432-024-06058-w.
2
Combining metabolomics and machine learning to discover biomarkers for early-stage breast cancer diagnosis.运用代谢组学和机器学习发现早期乳腺癌诊断的生物标志物。
PLoS One. 2024 Oct 21;19(10):e0311810. doi: 10.1371/journal.pone.0311810. eCollection 2024.
3
Is Lipid Metabolism of Value in Cancer Research and Treatment? Part I- Lipid Metabolism in Cancer.

本文引用的文献

1
Markers for detection of prostate cancer.用于前列腺癌检测的标志物。
Cancers (Basel). 2010 Jun 4;2(2):1125-54. doi: 10.3390/cancers2021125.
2
The role of choline in prostate cancer.胆碱在前列腺癌中的作用。
Clin Biochem. 2012 Dec;45(18):1548-53. doi: 10.1016/j.clinbiochem.2012.08.012. Epub 2012 Aug 19.
3
Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden.饮食脂肪酸摄入与瑞典厄勒布鲁郡前列腺癌生存情况。
脂质代谢在癌症研究与治疗中有价值吗?第一部分——癌症中的脂质代谢。
Metabolites. 2024 May 29;14(6):312. doi: 10.3390/metabo14060312.
4
Identification of Plasma Lipid Alterations Associated with Melanoma Metastasis.与黑色素瘤转移相关的血浆脂质改变的鉴定。
Int J Mol Sci. 2024 Apr 11;25(8):4251. doi: 10.3390/ijms25084251.
5
Lipid Biomarkers in Liquid Biopsies: Novel Opportunities for Cancer Diagnosis.液体活检中的脂质生物标志物:癌症诊断的新机遇
Pharmaceutics. 2023 Jan 28;15(2):437. doi: 10.3390/pharmaceutics15020437.
6
Targeting lipid metabolism in metastatic prostate cancer.靶向转移性前列腺癌中的脂质代谢
Ther Adv Med Oncol. 2023 Jan 30;15:17588359231152839. doi: 10.1177/17588359231152839. eCollection 2023.
7
Circulating metabolite biomarkers: a game changer in the human prostate cancer diagnosis.循环代谢物生物标志物:人类前列腺癌诊断中的变革者。
J Cancer Res Clin Oncol. 2023 Mar;149(3):951-967. doi: 10.1007/s00432-022-04113-y. Epub 2022 Jun 28.
8
A Nutritional Metabolism Related Prognostic Scoring System for Patients With Newly Diagnosed Osteosarcoma.一种用于新诊断骨肉瘤患者的营养代谢相关预后评分系统。
Front Nutr. 2022 Apr 28;9:883308. doi: 10.3389/fnut.2022.883308. eCollection 2022.
9
Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls.肾、乳腺和前列腺癌患者的血浆脂质组学特征与健康对照不同。
Sci Rep. 2021 Oct 13;11(1):20322. doi: 10.1038/s41598-021-99586-1.
10
High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer.尿中磷脂酰胆碱/溶血磷脂酰胆碱比值高与前列腺癌有关。
Cancer Sci. 2021 Oct;112(10):4292-4302. doi: 10.1111/cas.15093. Epub 2021 Aug 19.
Am J Epidemiol. 2012 Aug 1;176(3):240-52. doi: 10.1093/aje/kwr520. Epub 2012 Jul 10.
4
Statistical interpretation of machine learning-based feature importance scores for biomarker discovery.基于机器学习的特征重要性评分在生物标志物发现中的统计解释。
Bioinformatics. 2012 Jul 1;28(13):1766-74. doi: 10.1093/bioinformatics/bts238. Epub 2012 Apr 25.
5
A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling.高脂肪饮食促进前列腺癌细胞增殖并激活 MCP-1/CCR2 信号通路。
Prostate. 2012 Dec 1;72(16):1779-88. doi: 10.1002/pros.22531. Epub 2012 Apr 18.
6
Diet, obesity, and prostate health: are we missing the link?饮食、肥胖与前列腺健康:我们是否忽略了其中的联系?
J Androl. 2012 Sep-Oct;33(5):763-76. doi: 10.2164/jandrol.111.015578. Epub 2012 Feb 9.
7
The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer.溶血磷脂酰胆碱酰基转移酶 1(LPCAT1)的表达水平与前列腺癌的进展相关。
Exp Mol Pathol. 2012 Feb;92(1):105-10. doi: 10.1016/j.yexmp.2011.11.001. Epub 2011 Nov 11.
8
Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.前列腺癌筛查——美国预防服务工作组遗漏了什么。
N Engl J Med. 2011 Nov 24;365(21):1949-51. doi: 10.1056/NEJMp1112191. Epub 2011 Oct 26.
9
Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.血清磷脂脂肪酸与前列腺癌风险:前列腺癌预防试验的结果。
Am J Epidemiol. 2011 Jun 15;173(12):1429-39. doi: 10.1093/aje/kwr027. Epub 2011 Apr 24.
10
Systemic alterations in concentrations and distribution of plasma phospholipids in prostate cancer patients.前列腺癌患者血浆磷脂浓度和分布的系统改变。
Med Oncol. 2012 Jun;29(2):809-14. doi: 10.1007/s12032-011-9914-z. Epub 2011 Mar 26.